Showing results (251-260 of 351) with videos related to
Sort By:
Pageof 36
Sexually Transmitted Diseases|February 9, 2018
Rising Chlamydia and Gonorrhoea Incidence and Associated Risk Factors Among Female Sex Workers in Australia: A Retrospective Cohort StudyDenton Callander, Hamish McManus, Rebecca Guy, et al.Sexually Transmitted Infections|June 7, 2019
Population-level diagnosis and care cascade for chlamydia in AustraliaRichard T Gray, Denton Callander, Jane S Hocking, et al.Communicable Diseases Intelligence Quarterly Report|May 17, 2007
Australia's notifiable diseases status, 2005: annual report of the National Notifiable Diseases Surveillance SystemRhonda Owen, Paul W Roche, Kirsty Hope, et al.Sexual Health|August 22, 2013
Are Australian sexual health clinics attracting priority populations?Hammad Ali, Basil Donovan, Christopher K Fairley, et al.AIDS Research and Human Retroviruses|June 9, 2009
Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppressionHelen Byakwaga, John M Murray, Kathy Petoumenos, et al.Methodsx|December 14, 2023
Development of recommendations for a minimum dataset for Identifying Social factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in pain researchEmma L Karran, Aidan G Cashin, Trevor Barker, et al.Peerj|April 27, 2023
The 'what' and 'how' of screening for social needs in healthcare settings: a scoping reviewEmma L Karran, Aidan G Cashin, Trevor Barker, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2012
A randomized study of pharmacokinetics, efficacy, and safety of 2 raltegravir plus atazanavir strategies in ART-treated adultsDianne Carey, Sarah L Pett, Mark Bloch, et al.AIDS (London, England)|August 8, 2013
Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapyAllison Martin, Cecilia Moore, Patrick W G Mallon, et al.Frontiers in Public Health|October 27, 2022
Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genesWilhelmina M Huston, Amba Lawrence, Bryan A Wee, et al.Pageof 36